AI-generated summary
The authors report a prospective study of 233 patients with segmental vitiligo randomly assigned to Yiqiqubai granule, 308-nm excimer laser, or both combined for 6 months. The combined group had higher effective and markedly effective rates and greater color-reverse rates than the single-treatment groups, which the authors describe as good clinical effect.
- Participants
- 233
- Who or what was studied
- Patients with segmental vitiligo treated at Shanghai General Hospital between February 2015 and August 2016
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The abstract does not describe blinding, control arm details, or long-term follow-up beyond the 6-month treatment period.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.